Responses
Immunotherapy biomarkers
Original research
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.